Little Rock, ARKANSAS4 Active Studies

Parkinsons Disease Clinical Trials in Little Rock, ARKANSAS

Find 4 actively recruiting parkinsons disease clinical trials in Little Rock, ARKANSAS. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
2,210
Enrolling

Recruiting Parkinsons Disease Studies in Little Rock

About Parkinsons Disease Clinical Trials in Little Rock

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 4 parkinsons disease clinical trials recruiting participants in Little Rock, ARKANSAS. These studies are seeking a combined 2,210 participants. Research is being sponsored by Hoffmann-La Roche, Biohaven Therapeutics Ltd., Impax Laboratories, LLC and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Little Rock — FAQ

Are there parkinsons disease clinical trials in Little Rock?

Yes, there are 4 parkinsons disease clinical trials currently recruiting in Little Rock, ARKANSAS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Little Rock?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Little Rock research site will contact you about next steps.

Are clinical trials in Little Rock free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Little Rock studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 4 active trials in Little Rock are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated March 2, 2026 from ClinicalTrials.gov